WT p53 increases IL-1RA expression, which represses colon and breast cancer cells proliferation in vitro and tumor growth in vivo, while mutant p53 represses IL-1RA expression, allowing IL-1β effects [121]. This evidence concerns the gene TP53 and breast carcinoma.